Search

Author/Creator Puttemans, Janik

1. CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma. (1st January 2021)

Authors:
De Veirman, Kim; Puttemans, Janik; Krasniqi, Ahmet; Ertveldt, Thomas; Hanssens, Heleen; Romao, Ema; Hose, Dirk; Goyvaert, Cleo; Vlummens, Philip; Muyldermans, Serge; Breckpot, Karine; Bruchertseifer, Frank; Morgenstern, Alfred; D'Huyvetter, Matthias; Devoogdt, Nick
Journal:
Oncoimmunology
Issue:
Volume 10:Number 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle. (2nd August 2016)

Authors:
Dekempeneer, Yana; Keyaerts, Marleen; Krasniqi, Ahmet; Puttemans, Janik; Muyldermans, Serge; Lahoutte, Tony; D'huyvetter, Matthias; Devoogdt, Nick
Journal:
Expert opinion on biological therapy
Issue:
Volume 16:Number 8(2016:Aug.)
Page Start:
1035
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search